Ethical and scientific issues of nanotechnology in the workplace.

In the absence of scientific clarity about the potential health effects of occupational exposure to nanoparticles, a need exists for guidance in decision making about hazards, risks, and controls. An identification of the ethical issues involved may be useful to decision makers, particularly employers, workers, investors, and health authorities. Because the goal of occupational safety and health is the prevention of disease in workers, the situations that have ethical implications that most affect workers have been identified. These situations include the a) identification and communication of hazards and risks by scientists, authorities, and employers; b) workers' acceptance of risk; c) selection and implementation of controls; d) establishment of medical screening programs; and e) investment in toxicologic and control research. The ethical issues involve the unbiased determination of hazards and risks, nonmaleficence (doing no harm), autonomy, justice, privacy, and promoting respect for persons. As the ethical issues are identified and explored, options for decision makers can be developed. Additionally, societal deliberations about workplace risks of nanotechnologies may be enhanced by special emphasis on small businesses and adoption of a global perspective.

[1]  K. Shrader-Frechette.  Environmental Justice: Creating Equality, Reclaiming Democracy , 2002 .

[2]  T. Xia,et al.  Toxic Potential of Materials at the Nanolevel , 2006, Science.

[3]  Douglas K. Martin,et al.  Nanotechnology and the Developing World , 2005, PLoS medicine.

[4]  Edward Regis,et al.  Nano: The Emerging Science of Nanotechnology : Remaking the World-Molecule by Molecule , 1995 .

[5]  K. Pimple,et al.  Six domains of research ethics , 2002, Science and engineering ethics.

[6]  C. N. Davies,et al.  The Mechanics of Aerosols , 1964 .

[7]  Frances M. Lynn.  Public Participation in Risk Management Decisions: The Right to Define, The Right to Know and the Right to Act , 1990 .

[8]  M. Morandi,et al.  Nanoparticle‐induced platelet aggregation and vascular thrombosis , 2005, British journal of pharmacology.

[9]  John Weckert,et al.  Nanoethics: assessing the nanoscale from an ethical point of view , 2004 .

[10]  J. James,et al.  Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.

[11]  S. Samuels.  Occupational medicine and its moral discontents. , 2003, Journal of occupational and environmental medicine.

[12]  W. Halperin,et al.  Medical screening in the workplace: proposed principles. , 1986, Journal of occupational medicine. : official publication of the Industrial Medical Association.

[13]  A. Daar,et al.  ‘Mind the gap’: science and ethics in nanotechnology , 2003, The Ethics of Nanotechnology, Geoengineering and Clean Energy.

[14]  J. James,et al.  A Review of Carbon Nanotube Toxicity and Assessment of Potential Occupational and Environmental Health Risks , 2006, Critical reviews in toxicology.

[15]  Anthony Seaton,et al.  Nanotechnology and the occupational physician. , 2006, Occupational medicine.

[16]  David Berube,et al.  The Rhetoric of Nanotechnology , 2004 .

[17]  R. Aitken,et al.  Carbon nanotubes: a review of their properties in relation to pulmonary toxicology and workplace safety. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[18]  T J Lentz,et al.  Knowledge management in occupational hygiene: the United States example. , 2004, The Annals of occupational hygiene.

[19]  V. Weil.  Making sense of scientists’ responsibilities at the interface of science and society , 2002, Science and engineering ethics.

[20]  K. Eric Drexler,et al.  Engines of Creation , 1986 .

[21]  Debra L Laskin,et al.  Smaller is not always better: nanotechnology yields nanotoxicology. , 2005, American journal of physiology. Lung cellular and molecular physiology.

[22]  K. Donaldson,et al.  Inhalation of poorly soluble particles. II. Influence Of particle surface area on inflammation and clearance. , 2000, Inhalation toxicology.

[23]  Per Langaa Jensen,et al.  Assessing Assessment: The Danish Experience of Worker Participation in Risk Assessment , 2002 .

[24]  W. Bainbridge,et al.  Societal implications of nanoscience and nanotechnology , 2001 .

[25]  Arthur Kantrowitz,et al.  The Separation of Facts and Values , 1995 .

[26]  G. Oberdörster,et al.  Nanotoxicology: An Emerging Discipline Evolving from Studies of Ultrafine Particles , 2005, Environmental health perspectives.

[27]  Wolfgang Koch,et al.  Chronic Inhalation Exposure of Wistar Rats and two Different Strains of Mice to Diesel Engine Exhaust, Carbon Black, and Titanium Dioxide , 1995 .

[28]  Nicholas Frank Pidgeon,et al.  Harnessing Nanotechnology to Improve Global Equity , 2005 .

[29]  A. Maynard,et al.  Airborne Nanostructured Particles and Occupational Health , 2005 .

[30]  Stephen A.W. Drew,et al.  Building Knowledge Management into Strategy: Making Sense of a New Perspective , 1999 .

[31]  P. Baron,et al.  Unusual inflammatory and fibrogenic pulmonary responses to single-walled carbon nanotubes in mice. , 2005, American journal of physiology. Lung cellular and molecular physiology.

[32]  Guk-Rwang Won.  American Society for Testing and Materials , 1987 .

[33]  B. Fischhoff,et al.  Acceptable Risk: A Conceptual Proposal , 1994 .

[34]  James T. Bartis,et al.  Nanomaterials in the Workplace: Policy and Planning Workshop on Occupational Safety and Health , 2006 .

[35]  Adina Schwartz,et al.  Reason and Morality , 1979 .

[36]  Dana Loomis,et al.  Work in Brief , 2006 .

[37]  Karluss Thomas,et al.  Research strategies for safety evaluation of nanomaterials, part VIII: International efforts to develop risk-based safety evaluations for nanomaterials. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[38]  A. Peters,et al.  Particulate matter and heart disease: evidence from epidemiological studies. , 2005, Toxicology and applied pharmacology.

[39]  A. Gewirth.  Human rights and the workplace. , 1986, American journal of industrial medicine.

[40]  J. Finkelstein,et al.  Translocation of Inhaled Ultrafine Manganese Oxide Particles to the Central Nervous System , 2006, Environmental health perspectives.

[41]  John Cairns,et al.  Integrating top-down/bottom-up sustainability strategies: an ethical challenge , 2003 .